{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:30:07Z","timestamp":1787862607485,"version":"build-2784847793"},"reference-count":75,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00005-019-00543-8","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T02:04:16Z","timestamp":1556503456000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["The Influence of Antidepressants on the Immune System"],"prefix":"10.2478","volume":"67","author":[{"given":"\u0141ukasz P.","family":"Sza\u0142ach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna A.","family":"Lisowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw J.","family":"Cuba\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"543_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coph.2011.02.004","volume":"11","author":"GP Ahern","year":"2011","unstructured":"Ahern GP (2011) 5-HT and the immune system. Curr Opin Pharmacol 11:29\u201333","journal-title":"Curr Opin Pharmacol"},{"key":"543_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11481-017-9763-4","volume":"13","author":"D Ahmetspahic","year":"2018","unstructured":"Ahmetspahic D, Schwarte K, Ambr\u00e9e O et al (2018) Cell homeostasis in patients with major depressive disorder and normalization of CD5 surface expression on regulatory B cells in treatment responders. J Neuroimmune Pharmacol 13:90\u201399","journal-title":"J Neuroimmune Pharmacol"},{"key":"543_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phrs.2017.04.028","volume":"121","author":"E Alcocer-G\u00f3mez","year":"2017","unstructured":"Alcocer-G\u00f3mez E, Casas-Barquero N, Williams MR et al (2017) Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in major depressive disorder. Pharmacol Res 121:114\u2013121","journal-title":"Pharmacol Res"},{"key":"543_CR4","doi-asserted-by":"publisher","unstructured":"American Psychiatry Association (2013) Major depressive disorder. In: Diagnostic and statistical manual of mental disorders, 5th edn. Washington, DC, https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"543_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(94)90933-4","volume":"179","author":"WA Banks","year":"1994","unstructured":"Banks WA, Kastin AJ, Gutierrez EG (1994) Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 179:53\u201356","journal-title":"Neurosci Lett"},{"key":"543_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/bja\/aem218","volume":"99","author":"B Beilin","year":"2007","unstructured":"Beilin B, Rusabrov Y, Shapira Y et al (2007) Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth 99:522\u2013527","journal-title":"Br J Anaesth"},{"key":"543_CR7","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/mp.2011.100","volume":"17","author":"MH Bloch","year":"2012","unstructured":"Bloch MH, Hannestad J (2012) Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 17:1272\u20131282","journal-title":"Mol Psychiatry"},{"key":"543_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0165-0327(02)00264-1","volume":"72","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso S, Marino V, Biondi M et al (2002) Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord 72:237\u2013241","journal-title":"J Affect Disord"},{"key":"543_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/bja\/aeq169","volume":"105","author":"S Braun","year":"2010","unstructured":"Braun S, Gaza N, Werdehausen R et al (2010) Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells. Br J Anaesth 105:347\u2013354","journal-title":"Br J Anaesth"},{"key":"543_CR10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00213-013-3322-3","volume":"231","author":"AR Brunoni","year":"2014","unstructured":"Brunoni AR, Machado-Vieira R, Zarate CA et al (2014) Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology 231:1315\u20131323","journal-title":"Psychopharmacology"},{"key":"543_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jad.2015.07.006","volume":"185","author":"AR Brunoni","year":"2015","unstructured":"Brunoni AR, Machado-Vieira R, Sampaio-Junior B et al (2015) Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: results from the SELECT-TDCS trial. J Affect Disord 185:209\u2013213","journal-title":"J Affect Disord"},{"key":"543_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jad.2015.10.056","volume":"191","author":"YH Chou","year":"2016","unstructured":"Chou YH, Hsieh WC, Chen LC et al (2016) Association between the serotonin transporter and cytokines: implications for the pathophysiology of bipolar disorder. J Affect Disord 191:29\u201335","journal-title":"J Affect Disord"},{"key":"543_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/wps.20229","volume":"14","author":"P Cowen","year":"2015","unstructured":"Cowen P, Browning M (2015) What has serotonin to do with depression? World Psychiatry 14:158\u2013160","journal-title":"World Psychiatry"},{"key":"543_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jad.2013.10.004","volume":"152\u2013154","author":"WJ Cuba\u0142a","year":"2014","unstructured":"Cuba\u0142a WJ, Landowski J (2014) C-reactive protein and cortisol in drug-na\u00efve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease. J Affect Disord 152\u2013154:534\u2013537","journal-title":"J Affect Disord"},{"key":"543_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1684\/mrh.2016.0413","volume":"29","author":"WJ Cuba\u0142a","year":"2016","unstructured":"Cuba\u0142a WJ, Landowski J, Dziadziuszko M et al (2016) Magnesium, C-reactive protein, and cortisol in drug-na\u00efve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium. Magnes Res 29:169\u2013174","journal-title":"Magnes Res"},{"key":"543_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","volume":"45","author":"J Dahl","year":"2014","unstructured":"Dahl J, Ormstad H, Aass HC et al (2014) The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 45:77\u201386","journal-title":"Psychoneuroendocrinology"},{"key":"543_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0006-3223(89)90018-8","volume":"26","author":"DF Darko","year":"1989","unstructured":"Darko DF, Gillin JC, Risch SC et al (1989) Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression. Biol Psychiatry 26:145\u2013155","journal-title":"Biol Psychiatry"},{"key":"543_CR18","first-page":"2253","volume":"11","author":"S Demir","year":"2015","unstructured":"Demir S, Atli A, Bulut M et al (2015) Neutrophil\u2013lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat 11:2253\u20132258","journal-title":"Neuropsychiatr Dis Treat"},{"key":"543_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.phrs.2015.11.021","volume":"109","author":"ME Rosso Di","year":"2016","unstructured":"Di Rosso ME, Palumbo ML, Genaro AM (2016) Immunomodulatory effects of fluoxetine: a new potential pharmacological action for a classic antidepressant drug? Pharmacol Res 109:101\u2013107","journal-title":"Pharmacol Res"},{"key":"543_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"issue":"Suppl 1","key":"543_CR21","first-page":"170","volume":"28","author":"T Dubois","year":"2016","unstructured":"Dubois T, Zdanowicz N, Reynaert C et al (2016) Depression, family and immunity: influence of humoral immunity on family relationships and on the severity of depression. Psychiatr Danub 28(Suppl 1):170\u2013174","journal-title":"Psychiatr Danub"},{"key":"543_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.intimp.2009.01.011","volume":"9","author":"F Fazzino","year":"2009","unstructured":"Fazzino F, Urbina M, Cede\u00f1o N et al (2009) Fluoxetine treatment to rats modifies serotonin transporter and cAMP in lymphocytes, CD4+\u2009and CD8+\u2009subpopulations and interleukins 2 and 4. Int Immunopharmacol 9:463\u2013467","journal-title":"Int Immunopharmacol"},{"key":"543_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cyto.2011.06.022","volume":"56","author":"M Gao","year":"2011","unstructured":"Gao M, Jin W, Qian Y et al (2011) Effect of N-methyl-d-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 56:458\u2013465","journal-title":"Cytokine"},{"key":"543_CR24","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00213-015-3943-9","volume":"233","author":"L Grosse","year":"2016","unstructured":"Grosse L, Carvalho LA, Birkenhager TK et al (2016) Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology 233:1679\u20131688","journal-title":"Psychopharmacology"},{"key":"543_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP et al (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215","journal-title":"Brain Behav Immun"},{"key":"543_CR26","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, Dellagioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:2452\u20132459","journal-title":"Neuropsychopharmacology"},{"key":"543_CR27","unstructured":"Hilal-Dandan R, Brunton LL (2014) Chapter 42: pharmacology of the adrenal cortex. In: Goodman and Gilman\u2019s manual of pharmacology and therapeutics, 2nd edn. McGraw-Hill, New York"},{"key":"543_CR28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jpsychires.2010.03.005","volume":"44","author":"H Himmerich","year":"2010","unstructured":"Himmerich H, Milenovi\u0107 S, Fulda S et al (2010) Regulatory T cells increased while IL-1\u03b2 decreased during antidepressant therapy. J Psychiatr Res 44:1052\u20131057","journal-title":"J Psychiatr Res"},{"key":"543_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jss.2016.02.031","volume":"203","author":"M Hou","year":"2016","unstructured":"Hou M, Zhou NB, Li H et al (2016) Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4(+)CD25(+)Foxp3(+) regulatory T cells in vitro. J Surg Res 203:306\u2013312","journal-title":"J Surg Res"},{"key":"543_CR30","doi-asserted-by":"publisher","unstructured":"Inserra A, Mastronardi CA, Rogers G et al (2018) Neuroimmunomodulation in major depressive disorder: focus on caspase 1, inducible nitric oxide synthase, and interferon-gamma. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-018-1359-3","DOI":"10.1007\/s12035-018-1359-3"},{"key":"543_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neubiorev.2014.01.008","volume":"40","author":"RA Iseme","year":"2014","unstructured":"Iseme RA, McEvoy M, Kelly B et al (2014) Autoantibodies and depression: evidence for a causal link? Neurosci Biobehav Rev 40:62\u201379","journal-title":"Neurosci Biobehav Rev"},{"key":"543_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11055-007-0047-y","volume":"37","author":"SA Ivanova","year":"2007","unstructured":"Ivanova SA, Semke VY, Vetlugina TP et al (2007) Signs of apoptosis of immunocompetent cells in patients with depression. Neurosci Behav Physiol 37:527\u2013530","journal-title":"Neurosci Behav Physiol"},{"key":"543_CR33","first-page":"587","volume":"53","author":"B Karolewicz","year":"2001","unstructured":"Karolewicz B, Paul IA, Antkiewicz-Michaluk L (2001) Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol J Pharmacol 53:587\u2013596","journal-title":"Pol J Pharmacol"},{"key":"543_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/BF03016701","volume":"48","author":"C Kawasaki","year":"2001","unstructured":"Kawasaki C, Kawasaki T, Ogata M et al (2001) Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood. Can J Anesth 48:819\u2013823","journal-title":"Can J Anesth"},{"key":"543_CR35","doi-asserted-by":"publisher","first-page":"e1065","DOI":"10.1038\/tp.2017.31","volume":"7","author":"DD Kiraly","year":"2017","unstructured":"Kiraly DD, Horn SR, Van Dam NT et al (2017) Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl Psychiatry 7:e1065","journal-title":"Transl Psychiatry"},{"key":"543_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S1461145710000738","volume":"14","author":"AB Klein","year":"2011","unstructured":"Klein AB, Williamson R, Santini MA et al (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14:347\u2013353","journal-title":"Int J Neuropsychopharmacol"},{"key":"543_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, Benros ME, Nordentoft M et al (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71:1381\u20131391","journal-title":"JAMA Psychiatry"},{"key":"543_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1192\/bjp.148.1.70","volume":"148","author":"Z Kronfol","year":"1986","unstructured":"Kronfol Z, House JD, Silva J et al (1986) Depression, urinary free cortisol excretion and lymphocyte function. Br J Psychiatry 148:70\u201373","journal-title":"Br J Psychiatry"},{"key":"543_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","volume":"201","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK, Bhutani MK, Bishnoi M (2008) Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 201:435\u2013442","journal-title":"Psychopharmacology"},{"key":"543_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/00000542-199811000-00023","volume":"89","author":"B Larsen","year":"1998","unstructured":"Larsen B, Hoff G, Wilhelm W et al (1998) Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood. Anesthesiology 89:1218\u20131227","journal-title":"Anesthesiology"},{"key":"543_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s11064-012-0967-y","volume":"38","author":"S Malynn","year":"2013","unstructured":"Malynn S, Campos-Torres A, Moynagh P et al (2013) The pro-inflammatory cytokine TNF-\u03b1 regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Neurochem Res 38:694\u2013704","journal-title":"Neurochem Res"},{"key":"543_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jpsychires.2008.03.014","volume":"43","author":"F Matrisciano","year":"2009","unstructured":"Matrisciano F, Bonaccorso S, Ricciardi A et al (2009) Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6\u00a0months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res 43:247\u2013254","journal-title":"J Psychiatr Res"},{"key":"543_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"VP Menon","year":"2007","unstructured":"Menon VP, Sudheer AR (2007) Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595:105\u2013125","journal-title":"Adv Exp Med Biol"},{"key":"543_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-5728(99)00144-7","volume":"101","author":"A Mizruchin","year":"1999","unstructured":"Mizruchin A, Gold I, Krasnov I et al (1999) Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system. J Neuroimmunol 101:201\u2013204","journal-title":"J Neuroimmunol"},{"key":"543_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0278-5846(93)90055-W","volume":"17","author":"N M\u00fcller","year":"1993","unstructured":"M\u00fcller N, Hofschuster E, Ackenheil M et al (1993) Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 17:713\u2013730","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"543_CR46","volume-title":"Depresja","author":"S Murawiec","year":"2016","unstructured":"Murawiec S, Wierzbi\u0144ski P (2016) Depresja. VM Media, Gda\u0144sk"},{"key":"543_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-4939-2895-8_9","volume":"872","author":"E Oppong","year":"2015","unstructured":"Oppong E, Cato AC (2015) Effects of glucocorticoids in the immune system. Adv Exp Med Biol 872:217\u2013233","journal-title":"Adv Exp Med Biol"},{"key":"543_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2567.2007.02731.x","volume":"123","author":"\u00c9 P\u00e1llinger","year":"2008","unstructured":"P\u00e1llinger \u00c9, Csaba G (2008) A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells. Immunology 123:584\u2013589","journal-title":"Immunology"},{"key":"543_CR49","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/1099800414555411","volume":"17","author":"ED Papathanassoglou","year":"2015","unstructured":"Papathanassoglou ED, Miltiadous P, Karanikola MN (2015) May BDNF be implicated in the exercise-mediated regulation of inflammation? Critical review and synthesis of evidence. Biol Res Nurs 17:521\u2013539","journal-title":"Biol Res Nurs"},{"key":"543_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S2215-0366(15)00042-5","volume":"2","author":"CM Pariante","year":"2015","unstructured":"Pariante CM (2015) Psychoneuroimmunology or immunopsychiatry? Lancet Psychiatry 2:197\u2013199","journal-title":"Lancet Psychiatry"},{"key":"543_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","volume":"31","author":"CM Pariante","year":"2008","unstructured":"Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464\u2013468","journal-title":"Trends Neurosci"},{"key":"543_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.intimp.2015.06.031","volume":"28","author":"EJ Park","year":"2015","unstructured":"Park EJ, Lee JH, Jeong DC et al (2015) Natural killer cell activity in patients with major depressive disorder treated with escitalopram. Int Immunopharmacol 28:409\u2013413","journal-title":"Int Immunopharmacol"},{"key":"543_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fimmu.2018.00291","volume":"9","author":"K Patas","year":"2018","unstructured":"Patas K, Willing A, Demiralay C et al (2018) T cell phenotype and T cell receptor repertoire in patients with major depressive disorder. Front Immunol 9:291","journal-title":"Front Immunol"},{"key":"543_CR54","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.intimp.2005.02.005","volume":"5","author":"S Pe\u00f1a","year":"2005","unstructured":"Pe\u00f1a S, Baccichet E, Urbina M et al (2005) Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients. Int Immunopharmacol 5:1069\u20131076","journal-title":"Int Immunopharmacol"},{"key":"543_CR55","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1038\/s41598-018-21769-0","volume":"8","author":"K Pietruczuk","year":"2018","unstructured":"Pietruczuk K, Lisowska KA, Grabowski K et al (2018) Proliferation and apoptosis of T lymphocytes in patients with bipolar disorder. Sci Rep 8:3327","journal-title":"Sci Rep"},{"key":"543_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.autrev.2014.09.001","volume":"14","author":"M Postal","year":"2015","unstructured":"Postal M, Appenzeller S (2015) The importance of cytokines and autoantibodies in depression. Autoimmun Rev 14:30\u201335","journal-title":"Autoimmun Rev"},{"key":"543_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31\u201341","journal-title":"JAMA Psychiatry"},{"key":"543_CR58","volume-title":"Psychiatria tom I\u2014podstawy psychiatrii","author":"J Rybakowski","year":"2002","unstructured":"Rybakowski J (2002) Neuroimmunologia zaburze\u0144 psychicznych. In: Rybakowski J, Pu\u017cy\u0144ski S, Wci\u00f3rka J (eds) Psychiatria tom I\u2014podstawy psychiatrii. Elsevier Urban and Partner, Wroc\u0142aw"},{"key":"543_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0361-9230(94)00229-T","volume":"36","author":"NT Sandor","year":"1995","unstructured":"Sandor NT, Brassai A, Puskas A et al (1995) Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res Bull 36:483\u2013486","journal-title":"Brain Res Bull"},{"key":"543_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0165-1781(98)00133-4","volume":"85","author":"SJ Schleifer","year":"1999","unstructured":"Schleifer SJ, Keller SE, Bartlett JA (1999) Depression and immunity: clinical factors and therapeutic course. Psychiatry Res 85:63\u201369","journal-title":"Psychiatry Res"},{"key":"543_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpsychires.2014.04.021","volume":"55","author":"FM Schmidt","year":"2014","unstructured":"Schmidt FM, Lichtblau N, Minkwitz J et al (2014a) Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res 55:29\u201334","journal-title":"J Psychiatr Res"},{"key":"543_CR62","first-page":"288","volume":"26","author":"FM Schmidt","year":"2014","unstructured":"Schmidt FM, Kirkby KC, Himmerich H (2014b) The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression\u2014report of two cases. Psychiatr Danub 26:288\u2013290","journal-title":"Psychiatr Danub"},{"key":"543_CR63","first-page":"285","volume-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","author":"SM Stahl","year":"2013","unstructured":"Stahl SM (2013) Chapter 7: antidepressants. Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications, 4th edn. Cambridge University Press, New York, pp 285\u2013287","edition":"4"},{"key":"543_CR64","volume-title":"Immunologia","author":"T Stok\u0142osa","year":"2017","unstructured":"Stok\u0142osa T (2017) Psychoneuroimmunologia. In: Go\u0142\u0105b J, Jak\u00f3bisiak M, Lasek W, Stok\u0142osa T (eds) Immunologia, 7th edn. Wydawnictwo Naukowe PWN, Warszawa","edition":"7"},{"key":"543_CR65","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge R, Arnone D, Danese A et al (2015) Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 25:1532\u20131543","journal-title":"Eur Neuropsychopharmacol"},{"key":"543_CR66","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-041015-055340","volume":"34","author":"S Talbot","year":"2016","unstructured":"Talbot S, Foster SL, Woolf CJ (2016) Neuroimmunity: physiology and pathology. Ann Rev Immunol 34:421\u2013447","journal-title":"Ann Rev Immunol"},{"key":"543_CR67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11481-015-9620-2","volume":"10","author":"C Toben","year":"2015","unstructured":"Toben C, Baune BT (2015) An act of balance between adaptive and maladaptive immunity in depression: a role for T lymphocytes. J Neuroimmune Pharmacol 10:595\u2013609","journal-title":"J Neuroimmune Pharmacol"},{"key":"543_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR et al (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28\u201340","journal-title":"Am J Psychiatry"},{"key":"543_CR69","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.psychres.2015.06.002","volume":"228","author":"J Wei","year":"2015","unstructured":"Wei J, Zhang M, Zhou J (2015) Myeloid-derived suppressor cells in major depression patients suppress T-cell responses through the production of reactive oxygen species. Psychiatry Res 228:695\u2013701","journal-title":"Psychiatry Res"},{"key":"543_CR70","unstructured":"World Health Organization (2016) Mood (affective) disorders. In: The ICD-10 classification of mental and behavioral disorders. Geneva, block F30\u2013F39"},{"key":"543_CR71","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbi.2004.10.003","volume":"19","author":"CE Wright","year":"2005","unstructured":"Wright CE, Strike PC, Brydon L et al (2005) Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun 19:345\u2013350","journal-title":"Brain Behav Immun"},{"key":"543_CR72","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/JCP.0000000000000352","volume":"35","author":"JJ Yu","year":"2015","unstructured":"Yu JJ, Pei LB, Zhang Y et al (2015) Chronic supplementation of curcumin enhances the efficacy of antidepressants in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 35:406\u2013410","journal-title":"J Clin Psychopharmacol"},{"key":"543_CR73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1254\/jphs.11113FP","volume":"117","author":"J Zeng","year":"2011","unstructured":"Zeng J, Xia S, Zhong W et al (2011) In vitro and in vivo effects of ketamine on generation and function of dendritic cells. J Pharmacol Sci 117:170\u2013179","journal-title":"J Pharmacol Sci"},{"key":"543_CR74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/brbi.2000.0597","volume":"15","author":"EP Zorrilla","year":"2001","unstructured":"Zorrilla EP, Luborsky L, McKay JR et al (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199\u2013226","journal-title":"Brain Behav Immun"},{"key":"543_CR75","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2741\/4363","volume":"20","author":"MH Zou","year":"2015","unstructured":"Zou MH (2015) Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation. Front Biosci 20:1116\u20131143","journal-title":"Front Biosci"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00543-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-019-00543-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00543-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:13Z","timestamp":1704228553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-019-00543-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1007\/s00005-019-00543-8","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All co-authors reported no biomedical financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}